BeOne Medicines AG (ONC)

Oncolytics Biotech (TSE:ONC) Share Price Crosses Below 200 Day Moving Average – Here’s Why

Biotech Leader BeOne Medicines Poised To Hit Early Buy Points

BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Stock Has Consensus Target Price of $402.71

Head-To-Head Analysis: BeOne Medicines (NASDAQ:ONC) versus NRx Pharmaceuticals (NASDAQ:NRXP)

BeOne Medicines AG (ONC) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

BeOne Medicines (NASDAQ:ONC) Insider Sells $13,365,991.70 in Stock

Oncolytics Biotech (TSE:ONC) Shares Pass Above Two Hundred Day Moving Average – Here’s Why

Nykredit A S Invests $1.20 Million in BeOne Medicines Ltd. – Sponsored ADR $ONC

Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers

BeOne Medicines to Present at the Morgan Stanley Annual Global Healthcare Conference

BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines

BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer

BeOne Medicines Ltd. - Sponsored ADR (ONC) is a Great Momentum Stock: Should You Buy?

BeOne Medicines Ltd. - Sponsored ADR (ONC) Now Trades Above Golden Cross: Time to Buy?

BeOne Medicines Announces U.S. FDA Approval for TEVIMBRA-Based Regimen for First-Line HER2+ GEA

BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

Dimensional Fund Advisors LP Raises Position in BeOne Medicines Ltd. – Sponsored ADR $ONC

BeOne Medicines Q2 Earnings Call Highlights

BeOne Medicines AG (ONC) Q2 2026 Earnings Call Transcript